News Category
GeoVax announced preclinical findings that its enhanced MVA-X vaccine provides durable single-dose protection against highly pathogenic Clade I mpox, ...
GeoVax highlights its MVA-based hemorrhagic fever vaccine candidates as the Bundibugyo Ebola outbreak in Congo becomes the fastest-growing on record, ...
GeoVax Labs highlights the U.S. government's recent ACAM2000 procurement as strategic validation for long-term vaccine readiness and its own GEO-MVA p...
GeoVax Labs' CEO David Dodd comments on recent pharmaceutical acquisitions by Eli Lilly, interpreting them as a strategic shift toward viewing vaccine...
GeoVax Labs CEO David Dodd will present on building a resilient infectious disease strategy using MVA-based vaccine technologies in a May 28 webinar, ...
ARMR Sciences completed a private placement to fund its fentanyl vaccine, which is backed by the U.S. Department of Defense and aims to prevent fatal ...
